American Society of Hematology

SHERPA: Blue

People

  1. Levine
    Levine
  2. Koche
    Koche
  3. Abdel-Wahab
    Abdel-Wahab
  4. Chiosis
    Chiosis
  5. Dong
    Dong
  6. Drill
    Drill
  7. Gonen
    Gonen
  8. Kentsis
    Kentsis
  9. Shukla
    Shukla
  10. Stein
    Stein

Groups

  1. Center for Hematologic Malignancies (5)
  2. Adult Leukemia (4)
  3. Department of Medicine (4)
  4. Hematologic Malignancies, Division of (4)
  5. Executive Committee, Center for Hematologic Malignancies (3)
  6. GSK Faculty (3)
  7. Human Oncology and Pathogenesis Program (3)
  8. Pediatrics, Department of (3)
  9. Sloan Kettering Institute Postdocs (3)
  10. Alumni (GSK) (2)
Search Within
  1. "2015"
  2. "Center for Hematologic Malignancies"
  3. "Scott Armstrong"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (1)
Groups
  1. Center for Hematologic Malignancies (5)
  2. Adult Leukemia (4)
  3. Department of Medicine (4)
  4. Hematologic Malignancies, Division of (4)
  5. Executive Committee, Center for Hematologic Malignancies (3)
  6. GSK Faculty (3)

More Groups

People
  1. Scott Armstrong (5)
  2. Andrei Krivtsov (4)
  3. Richard Koche (3)
  4. Ross Levine (3)
  5. Efthymia Papalexi (2)
  6. Martin Tallman (2)

More People

Years
  1. 2015 (5)
Publications
  1. Blood (5)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1 study of the DOT1L inhibitor, pinometostat (EPZ-5676), in adults with relapsed or refractory leukemia: Safety, clinical activity, exposure and target inhibition
    Meeting Abstract

    Stein, E. M.; Garcia-Manero, G.; Rizzieri, D. A.; Tibes, R.; Berdeja, J. G.; Jongen-Lavrencic, M.; Altman, J. K.; Dohner, H.; Thomson, B.; Blakemore, S. J.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Preliminary report of the phase 1 study of the DOT1L inhibitor, pinometostat, EPZ-5676, in children with relapsed or refractory MLL-r acute leukemia: Safety, exposure and target inhibition
    Meeting Abstract

    Shukla, N.; O'Brien, M. M.; Silverman, L. B.; Pauly, M.; Wetmore, C.; Loh, M. L.; Whitlock, J. A.; Brown, P.; Thomson, B.; Blakemore, S. J.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • BAP1 loss results in EZH2-dependent transformation in myelodysplastic syndromes
    Meeting Abstract

    LaFave, L. M.; Beguelin, W.; Koche, R.; Teater, M.; Papalexi, E.; Spitzer, B.; Knutson, S.; Campbell, J.; Keilhack, H.; Thomas, P. M.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Genomic and proteomic analysis of primary chemoresistance and induction failure in acute myeloid leukemia
    Meeting Abstract

    Brown, F.; Still, E.; Cifani, P.; Ficarro, S.; Pouliot, G.; Drill, E.; Gonen, M.; He, J.; Balasubramanian, S.; Zhong, S.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Tumor-specific HSP90 inhibition as a therapeutic approach in JAK-mutant acute lymphoblastic leukemias
    Journal Article

    Kucine, N.; Marubayashi, S.; Bhagwat, N.; Papalexi, E.; Koppikar, P.; Martin, M. S.; Dong, L.; Tallman, M. S.; Paietta, E.; Wang, K.; more...
    Blood (2015)

    Fulltext@MSK | Save